Cytokines as markers of bacterial sepsis in newborn infants: A review

Pediatric Infectious Disease Journal

Volumn 19, Issue 9, 2000, Pages 879-887

  Mehr, Sam ^a,b   Doyle, Lex W ^a,b  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cytokine; Diagnosis; Interleukin; Newborn infant; Sepsis

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; IMMUNOASSAY; NEWBORN; NEWBORN SEPSIS; PRIORITY JOURNAL; REVIEW;

EID: 0033835716     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200009000-00014     Document Type: Review

References (49)

1. Control of antimicrobial resistance: Time for action
2. Diagnostic tests for bacterial infection from birth to 90 days: A systematic review
3. Acute phase reactants in neonatal bacterial infection
4. Receiver operating characteristic curves for comparison of serial neutrophil band forms and C reactive protein in neonates at risk of infection
5. Role of cytokines in sepsis
6. Cytokines and the hepatic acute phase response
7. Release of polymorphonuclear leukocytes from the bone marrow by interleukin-8
8. Serum tumour necrosis factor in newborns at risk for infections
9. Neonatal interleukin-1-beta, interleukin-6, and tumor necrosis factor: Cord blood levels and cellular production
10. Interleukin 6 as early mediator in neonatal sepsis
11. Tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 plasma levels in neonatal sepsis
12. Serum TNF levels in neonatal sepsis and septic shock
13. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis
14. Neonatal tumor necrosis factor, interleukin-1-alpha, interleukin-1-beta and interleukin-6 response to infection
15. Blood serum concentration of C-reactive protein and interleukin-6 in diagnosis of neonatal infections
16. Inflammatory and immunological markers in preterm infants: Correlation with disease
17. Umbilical cord blood interleukin-6 levels and neonatal morbidity
18. G-CSF, GM-CSF and IL-6 levels in cord blood: Diminished increase of G-CSF and IL-6 in preterm infection compared to term neonates
19. Interleukin-6: A sensitive parameter for the early diagnosis of neonatal bacterial infection
20. Bloodstream infections in neonatal intensive care unit patients: Results of a multicenter study
21. Role of tumor necrosis factor in neonatal sepsis
22. Predictive value of soluble immunological mediators in neonatal infection
23. Diagnostic value of plasma levels of tumor necrosis factor alpha (TNF alpha) and interleukin-6 (IL-6) in newborns with sepsis
24. Interleukin-6 and soluble interleukin-6 receptor in cord blood in the diagnosis of early onset sepsis in neonates
25. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection
26. Immunologic parameters in cord blood indicating early-onset sepsis
27. Value of umbilical artery and vein levels on interleukin-6 and soluble intracellular adhesion molecule-1 as predictors of neonatal hematologic indices and suspected early sepsis
28. Interleukin 6 in neonates with early and late onset infection
29. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants
30. Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation
31. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1-beta and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis
32. Interleukin-6 concentrations in neonates evaluated for sepsis
33. Interleukin-6 concentration in neonatal sepsis
34. Maternal chorioamnionitis and umbilical vein interleukin-6 levels for identifying early neonatal sepsis
35. Evaluation of interleukin-6, tumour necrosis factor-alpha and interleukin-1 beta for early diagnosis of neonatal sepsis
36. Comparison of procalcitonin with interleukin 8, C-reactive protein and differential white blood cell count for the early diagnosis of bacterial infections in newborn infants
37. Contribution of interleukin-6 in distinguishing between mild respiratory disease and neonatal sepsis in the newborn infant
38. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections
39. Users' guides to the medical literature: III. How to use an article about a diagnostic test. A: Are the results of the study valid?
40. Immediate postmortem cultures in an intensive care nursery
41. Frequency of low level bacteremia in infants from birth to two months of age
42. Clinicopathologic approach to the diagnosis of neonatal sepsis
43. Neonatal nosocomial infections
44. Elevation of circulating interleukin-6 after surgery: Factors influencing the serum level
45. Differential effects of indomethacin and dexamethasone on cytokine production in carrageenin-induced rat pleurisy
46. Interleukin-8 in cord sera: A sensitive and specific marker for the detection of preterm chorioamnionitis
47. Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: Influence of antibiotic class, antibiotic concentration, and presence of septic serum
48. Interleukin-6 concentrations in neonatal sepsis
49. Serum concentrations of interleukin-6 are increased when sampled through an indwelling venous catheter